- Poster presentation
- Open Access
Genetic polymorphisms of inflammatory molecules in Tunisian inflammatory bowel diseases
© Gorgi et al; licensee BioMed Central Ltd. 2010
- Published: 25 November 2010
- Inflammatory Bowel Disease
- Ulcerative Colitis
- Inflammatory Bowel Disease Patient
- Ulcerative Colitis Patient
- Immunosuppressive Regimen
To detect a possible association between the functional polymorphisms of these molecules and susceptibility to Crohn’s disease (CD) and ulcerative colitis (UC) in Tunisian population.
We have analysed polymorphisms of CCR5-Δ32, CCR5-59029-A/G, CCR2-V64I, MCP-1 G/A (-2518), ICAM-1 G241R, PECAM-1 V125L, E-selectin L554F and L-selectin F206L in 194 Inflammatory bowel disease (IBD) patients and 169 healthy blood donors using PCR-RFLP and PCR-SSP methods. The patients were classified in 126 patients with CD and 68 patients with UC.
A significant increase in allele frequency of 206L of L-selectin was observed in IBD patients compared with controls (OR: 1.53; 95%CI: [1.05-5.60]; p=0.02) but does not constitute factor influencing clinical manifestations. The genotypic and allelic frequencies of chemokine polymorphisms did not reveal significant differences between patients and controls, and among CD and UC patients. However, analysis of CD patients revealed that those carrying A/A and/or A/G CCR5-59029 genotypes are more frequently in remission compared to those with G/G genotype (OR: 0.4; 95%CI: [0.174-0.928]; p=0.03). Also, the frequency of the 64I CCR2 muted allele was statistically higher in CD patients in remission disease than those in active form (OR: 0.267; 95%CI: [0.09-0.78]; p=0.01). Adjustment for known covariates factors (age, gender and immunosuppressive regimen) confirmed these univariate findings and revealed that the A/G CCR5-59029 and V64I CCR2 genotype were associated to remission form of CD (OR: 2.63 ; 95%CI: [1.01-6.80] ; p=0.047 and OR: 4.64 ; 95%CI: [1.01-21.31] ; p=0.049 respectively).
The present study supports the involvement of chemokine receptor (CCR2 and CCR5) polymorphisms on the susceptibility to clinical course of IBD in Tunisian patients. However, further studies are needed to confirm the association of these diseases with allele L206 of L-selectin gene.
- Dong VM, McDermott DH, Abdi R: Chemokines and diseases. Eur J Dermatol. 2003, 13: 224-30.PubMedGoogle Scholar
- Palmieri O, Latiano A, Salvatori E: The -A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease. Am J Gastroenterol. 2010, 105 (7): 1586-94. 10.1038/ajg.2010.4.View ArticlePubMedGoogle Scholar
- Herfarth H, Gökem M, Hellerbrand C: Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. International journal of colorectal disease. 2003, 18: 401-5. 10.1007/s00384-003-0477-0.View ArticlePubMedGoogle Scholar
- Rector A, Vermeire S, Thoelen I: Analysis of the CC chemokine receptor 5(CCR5) delta-32 polymorphism in inflammatory bowel disease. Hum Genet. 2001, 108: 190-193. 10.1007/s004390100462.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.